#EASD26: Regeneron’s antibody helps patients regain muscle after stopping GLP-1 therapy – Endpoints News

#EASD26: Regeneron’s antibody helps patients regain muscle after stopping GLP-1 therapy  Endpoints NewsRegeneron weight-loss drug halves muscle loss in combination with Novo’s semaglutide in trial  reuters.comThe Next Frontier for Obesity Drugs Isn’t How Much Weight You Lose, but What Kind  WSJPhase 2 COURAGE Trial Confirms Trevogrumab Prevents Lean Mass and Muscle Loss During GLP-1 Receptor Agonist-induced Weight Loss  Investing News NetworkPharma deals and data heat the weight-loss-drug market  Chemical & Engineering News